Table 1 Characterization of patients with HA who were positive for inhibitors
Patient number | Age (years) | Level of circulating FVIII | Severity | Historical peak of Bethesda titer (UB/mL) | Bethesda titer (UB/mL) at the time of blood collection |
|---|---|---|---|---|---|
1 | 11 | 2.0 | Moderate | 16.0 | 16.0 |
2 | 19 | <1.0 | Severe | 3.2 | 0.0 |
3 | 35 | <1.0 | Severe | 384.0 | 20.8 |
4 | 11 | 2.7 | Moderate | 12.8 | 8.4 |
5 | 14 | <1.0 | Severe | 192.0 | 20.8 |
6 | 13 | 1.9 | Moderate | 5.8 | 5.8 |
7 | 40 | <1.0 | Severe | 93.0 | 16.0 |
8 | 19 | <1.0 | Severe | 160.0 | 12.0 |
9 | 27 | <1.0 | Severe | 5.4 | 5.4 |
10 | 6 | 4.0 | Moderate | 14.4 | 6.4 |
11 | 37 | 1.8 | Moderate | 128.0 | 0.6 |
12 | 22 | <1.0 | Severe | 288.0 | 115.2 |
13 | 31 | <1,0 | Severe | 25.6 | 14.4 |
14 | 14 | 2.9 | Moderate | 36.0 | 5,2 |
15 | 8 | 1.0 | Severe | 384.0 | 4.6 |
16 | 16 | <1.0 | Severe | 7.0 | 2.8 |
17 | 38 | <1.0 | Severe | 48.0 | 0.3 |
18 | 8 | 2.8 | Moderate | 768.0 | 2.0 |
19 | 10 | 1.0 | Severe | 48.0 | 1.2 |
20 | 36 | 1.5 | Moderate | 13.0 | 0.0 |
21 | 14 | <1.0 | Severe | 52.0 | 13.2 |
22 | 39 | <1.0 | Severe | 3.9 | 0.0 |
23 | 1 | 1.6 | Moderate | 6.6 | 0.5 |
24 | 23 | <1.0 | Severe | 224.0 | 1.4 |
25 | 57 | <1.0 | Severe | 20.8 | 1.0 |